Loading the company…
Loading the company…
Families: Debridement & negative-pressure wound therapy.
All companies · Product and company coverage
In 2025, Guard Medical reported engagement with 171 surgeons and other clinicians in the states MedaRep covers, worth $38K in consulting, speaking, meals and travel for its device products, the most in New Jersey ($21K to 16). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: New Jersey ($21K, 16 engaged), New York ($6,045, 32 engaged), California ($5,682, 17 engaged), Florida ($4,023, 81 engaged), Ohio ($260, 7 engaged).
In the last ten years FDA made 7 decisions for Guard Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2025 (2). The latest was on 2025-05-15.
| Family | Decisions on record |
|---|---|
| Debridement & negative-pressure wound therapy | 7 |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Guard Medical.